Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancerAntonino Musolino, Maria Michiara, Daniela Boggiani et al.|Critical Reviews in Oncology/Hematology|2020Cited by 21
Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer?Silvia Paola Corona, Daniele Generali, Giovanni Allevi et al.|Future Oncology|2017Cited by 6